Dr Calvin Flynn

Dr Calvin Flynn is a Medical Oncology Specialist Registrar currently completing the inaugural Goodman Fellowship in Early Phase Drug Development at START Dublin, based at the Mater Misericordiae University Hospital. He is also undertaking an MD at Systems Biology Ireland, University College Dublin.

His research focuses on KRAS-mutant cancers, exploring mechanisms of resistance to KRAS inhibition and developing translational biomarkers, aiming to bridge molecular oncology with early-phase clinical trials and support the development of more effective, targeted therapies.